Plasma arginine vasopressin and atrial natriuretic peptide concentration in patients with hyponatremia at diagnosis and following treatment

2007 ◽  
Vol 18 (3) ◽  
pp. 221-229 ◽  
Author(s):  
M.J. Coenraad ◽  
J.H. Bolk ◽  
M. Frölich ◽  
A.E. Meinders
1986 ◽  
Vol 4 (5) ◽  
pp. 623-629 ◽  
Author(s):  
Markus P. Gn??dinger ◽  
Peter Weidmann ◽  
Wolfgang Rascher ◽  
Rudolf E. Lang ◽  
Beat Hellm??ller ◽  
...  

1988 ◽  
Vol 75 (1) ◽  
pp. 35-39 ◽  
Author(s):  
M. J. Allen ◽  
V. T. Y. Ang ◽  
E. D. Bennett ◽  
J. S. Jenkins

1. Eight normal volunteers were infused with 5% saline (5 g of NaCl/100 ml) at a rate of 0.06 ml min−1 kg−1 for 120 min to increase plasma osmolality and plasma arginine vasopressin. Human atrial natriuretic peptide (α-hANP; 100 μg) or placebo was given in random order in a double-bind cross-over design for the last 20 min of the saline infusion. 2. Compared with the placebo infusion, atrial natriuretic peptide (ANP) produced a 43% greater sodium excretion and a 34% greater urinary volume in the subsequent hour. 3. Mean plasma immunoreactive ANP did not increase in response to changes in osmolality and rose to a peak of 118 pg/ml during the α-hANP infusion. α-hANP produced significant suppression of mean plasma arginine vasopressin over the 60 min after the infusions. 4. We conclude that ANP is not released in response to increased osmolality in vivo, and that it inhibits osmolality-induced arginine vasopressin release in man.


1993 ◽  
Vol 22 (suppl 2) ◽  
pp. P14-P14
Author(s):  
E. Mulkerrin ◽  
A. Brain ◽  
D. Hampton ◽  
D. Sykes ◽  
M.D. Penney ◽  
...  

1992 ◽  
Vol 6 (6) ◽  
pp. 686-691 ◽  
Author(s):  
Tetsuhiro Sakai ◽  
Terry W. Latson ◽  
Charles W. Whitten ◽  
David N. O'Flaherty ◽  
Dac Vu ◽  
...  

1990 ◽  
Vol 31 (4) ◽  
pp. 425-434 ◽  
Author(s):  
Motoyuki NAKAMURA ◽  
Naoshi ARAKAWA ◽  
Yasumi ABE ◽  
Hiroaki YOSHIDA ◽  
Shuetsu MIURA ◽  
...  

Author(s):  
M D Penney ◽  
D Hampton ◽  
D A Oleesky ◽  
C Livingstone ◽  
E Mulkerrin

A rapid vacuum-driven procedure, using pre-treated Sep-Pak C18 cartridges, has been developed for the simultaneous extraction of arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) from plasma. Non-specific interference was removed by fractional elution with an aqueous methanol/trifluoroacetic acid (TFA) mixture. AVP and ANP were coeluted under positive pressure with a methanol/TFA mixture and the eluates air-dried before measurement using separate radioimmunoassays. Assay ranges for AVP and ANP were 0·12–29·5 pmol/L and 0·65–162 pmol/L, respectively, with mean recoveries (standard deviation in parentheses) for AVP of 96·4% (5·5%) at a level of 11·8 pmol/L and for ANP of 94·8% (5·9%) at a level of 32·4 pmol/L. The extraction and assay procedures were validated by observing the changes in plasma AVP and ANP concentrations in normal subjects at different stages of hydration and in elderly patients during treatment for congestive cardiac failure.


Angiology ◽  
1992 ◽  
Vol 43 (10) ◽  
pp. 810-817
Author(s):  
Jiang Gu ◽  
Connie Daloisio ◽  
Michael D'Andrea ◽  
S. Muralidharan ◽  
Cheng-Zhi Yu ◽  
...  

Nephron ◽  
1988 ◽  
Vol 49 (2) ◽  
pp. 140-143 ◽  
Author(s):  
A.N. Elias ◽  
N.D. Vaziri ◽  
M.R. Pandian ◽  
D.R. Powers ◽  
E. Domurat

2009 ◽  
Vol 41 ◽  
pp. 105
Author(s):  
Karl J. New ◽  
Damian M. Bailey ◽  
Michael Penney ◽  
Catherine Templeton ◽  
Gethin Ellis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document